Klin Monbl Augenheilkd. 2009 May;226(5):388-95. doi: 10.1055/s-0028-1109432. Epub 2009 Jun 8.
The socioeconomic strategy and some scientific aspects in the management of exudative age related macular degeneration (AMD) have changed since the last publication on preferred practice pattern. Furthermore new drugs are tested in clinical trials. Consequently it seems reasonable to re-evaluate the recommendations for the treatment of exudative AMD.
自上次关于最佳实践模式的出版物发布以来,渗出性年龄相关性黄斑变性(AMD)管理中的社会经济策略和一些科学方面已经发生了变化。此外,新药正在临床试验中进行测试。因此,重新评估渗出性AMD的治疗建议似乎是合理的。